Johnson & Johnson
NYSE:JNJ
Johnson & Johnson
NYSE:JNJ
Price:
148.92 USD
0.23%
Market Closed
Updated:
May 7, 2024
Johnson & Johnson
Cash from Investing Activities
|
Johnson & Johnson
Cash from Investing Activities Peer Comparison
Comparables:
BMY
PFE
MRK
ZTS
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
-$2.9B
|
CAGR 3-Years
48%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$13.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Cash from Investing Activities
-$692m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-13%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.6B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Johnson & Johnson's Cash from Investing Activities?
Cash from Investing Activities
-2.9B
USD
-2.9B
USD
Based on the financial report for Mar 31, 2024, Johnson & Johnson's Cash from Investing Activities amounts to -2.9B USD.
What is Johnson & Johnson's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
7%
7%
Over the last year, the Cash from Investing Activities growth was 46%. The average annual Cash from Investing Activities growth rates for Johnson & Johnson have been 48% over the past three years , 5% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
